Inventor · disambiguated record
Jan Martin Berke
Also filed as: BERKE JAN · BERKE JAN MARTIN
5 granted patents·11 pending applications·4 citations·filing 2009–2021
64Inventor score
Files withJANSSEN SCIENCES IRELAND UNLIMITED CO11NOVIRA THERAPEUTICS INC2Janssen Sciences lreland Unlimited Company1STUYVER LIEVEN JOZEF1VIRCO BVBA1
Top patents by PatentIndex Score
16 records- 0180US10441589B2Combinations and methods comprising a capsid assembly inhibitorNOVIRA THERAPEUTICS INC·Filed 2017·Granted Oct 15, 2019·4 cites·4 claims
- 0266US11129834B2Combinations and methods comprising a capsid assembly inhibitorNOVIRA THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·0 cites·2 claims
- 0350US2023091047A1Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0447US11491148B2Amide derivatives useful in the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Nov 8, 2022·0 cites·19 claims
- 0547US2022242879A1Fused heterocycle derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0647US2022348592A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0746US2022305107A1COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAiJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0846US2022233526A1Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulatorsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0946US2022249647A1Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulatorsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1045US2022323455A1Fused heterocyclic derivatives as antiviral agentsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1145US2023228736A1In vitro hbv core protein assayJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1244US11096931B2Amide derivatives useful in the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Aug 24, 2021·0 cites·16 claims
- 1344US2022305116A1Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivativesJanssen Sciences lreland Unlimited Company·Filed 2020·Application pending·0 cites
- 1443US8945833B2Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6STUYVER LIEVEN JOZEF·Filed 2009·Granted Feb 3, 2015·0 cites·1 claims
- 1542US2022305117A1Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnaiJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1633US2016177407A1Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6VIRCO BVBA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Martin Berke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →